Back to today’s briefing

Story perspectives

Tofacitinib Offers Hope for Immunocompromised Children Battling COVID-19

1/15/2025

25 5

Summary

Story summary

Immunocompromised children, especially those with primary immunodeficiency diseases, face daunting challenges with COVID-19, including prolonged viral shedding and severe health risks. Genetic factors like the PTPN2 variant heighten their vulnerability. However, tofacitinib emerges as a beacon of hope, offering potential new treatments for these at-risk young patients.

1 of 1

Story summary

Immunocompromised children, especially those with primary immunodeficiency diseases, face daunting challenges with COVID-19, including prolonged viral shedding and severe health risks. Genetic factors like the PTPN2 variant heighten their vulnerability. However, tofacitinib emerges as a beacon of hope, offering potential new treatments for these at-risk young patients.